Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction

International Journal of Cardiology

Volumn 128, Issue 1, 2008, Pages 107-111

  Elmas, Elif ^a   Lang, Siegfried ^a   Dempfle, Carl Erik ^a   Kälsch, Thorsten ^a   Papassotiriou, Jana ^b   Morgenthaler, Nils G ^b   Borggrefe, Martin ^a   Brueckmann, Martina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BRAHMS AG   (Germany)

Author keywords

Adrenomedullin; Coronary artery disease; Left ventricular function

Indexed keywords

PROADRENOMEDULLIN;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; ENZYME SPECIFICITY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; ROC CURVE; SEX DIFFERENCE; UNIVARIATE ANALYSIS;

ADRENOMEDULLIN; AREA UNDER CURVE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 46149100497     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.117     Document Type: Article

References (18)

1. Hammerer-Lercher A., Puschendorf B., and Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab 47 (2001) 265-277
2. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
3. Richards A.M., Nicholls M.G., Yandle T.G., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart 81 (1999) 114-120
4. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
5. Beltowski J., and Jamroz A. Adrenomedullin-what do we know 10 years since its discovery?. Pol J Pharmacol 56 (2004) 5-27
6. Cheung B.M., Li C.Y., and Wong L.Y. Adrenomedullin: its role in the cardiovascular system. Semin Vasc Med 4 (2004) 129-134
7. Meeran K., O'Shea D., Upton P.D., et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 82 (1997) 95-100
8. Pio R., Martinez A., Unsworth E.J., et al. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276 (2001) 12292-12300
9. Struck J., Tao C., Morgenthaler N.G., and Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 25 (2004) 1369-1372
10. Morgenthaler N.G., Struck J., Alonso C., and Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51 (2005) 1823-1829
11. Jarolim P. Serum biomarkers for heart failure. Cardiovasc Pathol 15 (2006) 144-149
12. Nishikimi T., Yoshihara F., Mori Y., Kangawa K., and Matsuoka H. Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 26 (2003) S121-S127 [Suppl]
13. Nicholls M.G., Charles C.J., Lainchbury J.G., et al. Adrenomedullin in heart failure. Hypertens Res 26 (2003) S135-S140 [Suppl]
14. Hojo Y., Ikeda U., Mizuno O., Katsuki T.A., and Shimada K. Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis. Int J Cardiovasc Interv 5 (2003) 190-194
15. Jougasaki M., Grantham J.A., Redfield M.M., and Burnett Jr. J.C. Regulation of cardiac adrenomedullin in heart failure. Peptides 22 (2001) 1841-1850
16. Jougasaki M., Heublein D.M., Sandberg S.M., and Burnett Jr. J.C. Attenuated natriuretic response to adrenomedullin in experimental heart failure. J Card Fail 7 (2001) 75-83
17. Rademaker M.T., Charles C.J., Espiner E.A., Nicholls M.G., and Richards A.M. Long-term adrenomedullin administration in experimental heart failure. Hypertension 40 (2002) 667-672
18. Rademaker M.T., Cameron V.A., Charles C.J., Lainchbury J.G., Nicholls M.G., and Richards A.M. Adrenomedullin and heart failure. Regul Pept 112 (2003) 51-60